Sweden
· Delayed Price · Currency is SEK Apotea AB Statistics
Total Valuation
Apotea AB has a market cap or net worth of SEK 10.06 billion. The enterprise value is 10.45 billion.
| Market Cap | 10.06B |
| Enterprise Value | 10.45B |
Important Dates
The next estimated earnings date is Friday, July 18, 2025.
| Earnings Date | Jul 18, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Apotea AB has 104.07 million shares outstanding. The number of shares has increased by 1.08% in one year.
| Current Share Class | 104.07M |
| Shares Outstanding | 104.07M |
| Shares Change (YoY) | +1.08% |
| Shares Change (QoQ) | +0.92% |
| Owned by Insiders (%) | 0.45% |
| Owned by Institutions (%) | 49.92% |
| Float | 68.20M |
Valuation Ratios
The trailing PE ratio is 41.99 and the forward PE ratio is 45.82.
| PE Ratio | 41.99 |
| Forward PE | 45.82 |
| PS Ratio | 1.48 |
| PB Ratio | 14.23 |
| P/TBV Ratio | 15.76 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 40.09 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 23.83, with an EV/FCF ratio of -774.35.
| EV / Earnings | 43.96 |
| EV / Sales | 1.54 |
| EV / EBITDA | 23.83 |
| EV / EBIT | 35.68 |
| EV / FCF | -774.35 |
Financial Position
The company has a current ratio of 1.09, with a Debt / Equity ratio of 0.55.
| Current Ratio | 1.09 |
| Quick Ratio | 0.45 |
| Debt / Equity | 0.55 |
| Debt / EBITDA | 0.89 |
| Debt / FCF | -28.99 |
| Interest Coverage | 43.09 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 30.95% |
| Revenue Per Employee | 9.32M |
| Profits Per Employee | 327,098 |
| Employee Count | 800 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 82.47 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 73.19 |
| Average Volume (20 Days) | 281,875 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Apotea AB had revenue of SEK 6.78 billion and earned 237.80 million in profits. Earnings per share was 2.30.
| Revenue | 6.78B |
| Gross Profit | 1.86B |
| Operating Income | 293.00M |
| Pretax Income | 294.00M |
| Net Income | 237.80M |
| EBITDA | 374.13M |
| EBIT | 293.00M |
| Earnings Per Share (EPS) | 2.30 |
Balance Sheet
The company has 20.80 million in cash and 391.30 million in debt, giving a net cash position of -370.50 million or -3.56 per share.
| Cash & Cash Equivalents | 20.80M |
| Total Debt | 391.30M |
| Net Cash | -370.50M |
| Net Cash Per Share | -3.56 |
| Equity (Book Value) | 706.90M |
| Book Value Per Share | 6.59 |
| Working Capital | 91.20M |
Cash Flow
In the last 12 months, operating cash flow was 251.00 million and capital expenditures -264.50 million, giving a free cash flow of -13.50 million.
| Operating Cash Flow | 251.00M |
| Capital Expenditures | -264.50M |
| Free Cash Flow | -13.50M |
| FCF Per Share | -0.13 |
Margins
Gross margin is 27.49%, with operating and profit margins of 4.32% and 3.51%.
| Gross Margin | 27.49% |
| Operating Margin | 4.32% |
| Pretax Margin | 4.34% |
| Profit Margin | 3.51% |
| EBITDA Margin | 5.52% |
| EBIT Margin | 4.32% |
| FCF Margin | n/a |
Dividends & Yields
Apotea AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.08% |
| Shareholder Yield | n/a |
| Earnings Yield | 2.36% |
| FCF Yield | -0.13% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Apotea AB has an Altman Z-Score of 8.6.
| Altman Z-Score | 8.6 |
| Piotroski F-Score | n/a |